‘Skinny jabs’: weight-loss drugs set for new boom as generic versions emerge

Alternatives to costly Wegovy and Saxenda will make such treatments more widely available worldwide

• Ozempic maker invests $4bn to meet US skinny jab' demand

Medicines that enable dramatic weight loss are likely to experience a new boom in uptake, experts have said, as the first generic versions hit the market this week at a lower cost than the original drugs.

The injections, dubbed skinny jabs" by the media, can help people lose more than 10% of their body weight and have become hugely popular in recent years, with celebrities lauding their effects.